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The Crossover Femoropopliteal Bypass: A Useful Option for 
Unilateral Iliofemoral Occlusive Disease 
R. T. A. Chalmers*, J. Kerr, T. Gillies and J. Brittenden 
Vascular Surgery Unit, Royal Infirmary, Lauriston Place, Edinburgh, U.K. 
Objective: To study the outcome of treating critical limb ischaemia due to concurrent, unilateral iliac and femoral arterial 
occlusive disease by the placement of a crossover femoropopliteal bypass graft. 
Design: Retrospective study of 10 patients unfit for aortic reconstruction whose disease was not amenable to endovascular 
therapy who were treated with this graft. 
Materials: Seven grafts originated from the common femoral artery, two from aortobifemoral graft limbs and one from the 
common iliac artery. There was no direct revascularisation ofthe profunda femoris artery. The distal anastomosis was to 
the above-knee popliteal artery in nine cases and to the below-knee popliteal artery in one. 
Outome measures: Follow-up after discharge from hospital consisted of regular ankle-brachial index measurement and 
Duplex ultrasound scan assessment to record graft patency and limb salvage. 
Results: The median duration of secondary patency was 52.5 months (range 14--84). During follow-up, there were four 
occlusive vents. One graft had its patency restored, but in the other three patients, graft occlusion was associated with limb 
loss (at 18, 51 and 83 months respectively). In one of this latter group, surveillance had identified afailing graft and a jump 
graft prolonged patency for a further 34 months. 
Conclusion: This experience demonstrates that the crossover femoropopliteal bypass achieves atisfactory limb salvage in 
patients with extensive iliofemoraI occlusive disease who are not suitable for major aortic reconstruction. 
Introduction 
The traditional surgical treatment of patients with 
concurrent iliac and femoral arterial occlusive disease 
has been with the placement of an aortobifemoral 
bypass. 1 In some such cases, where inadequate distal 
revascularisation has been achieved via the profunda 
femortis artery, an additional "outflow" procedure, in 
the form of a femoropopliteal bypass has been 
advocated. 2'3 As far as unilateral iliac artery occlusive 
disease is concerned, the surgical options lie between 
an ipsilateral iliofemoral bypassff 5 femorofemoral 
crossover, 6'7 or axillofemoral grafting, s More recently, 
the advent of endovascular intervention has meant 
that a large proportion of these patients can be 
managed satisfactorily by percutaneous transluminal 
balloon angioplasty with or without stenting, thereby 
obviating the need for major surgery altogether. 
There is a sub-group of patients with unilateral 
iliofemoral occlusive disease, however, who are medi- 
cally unfit for aortic surgery and Whose pattern of 
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disease is not amenable to either endovascular recan- 
alisation or to the traditional bypass graft options. In 
such circumstances it has been our practice to place an 
extra-anatomic, crossover graft from the contralateral 
femoral artery to the popliteal artery on the sympto- 
matic side and this paper reports our experience with 
this operative technique. 
Patients and Methods 
Between 1985 and 1994, ten patients (7 men, 3 women) 
of median age 64 years (range 53-81) were treated for 
critical limb ischaemia with a crossover femoropopli- 
teal bypass graft in the Vascular Surgery Unit of the 
Royal Infirmary of Edinburgh. In the same time 
period, there were 636 surgical reconstructions per- 
formed for aortoiliac occlusive disease. 
Nine of the patients in this series presented with 
either pain at rest or non-healing ulceration and in one 
instance, a patient had an infected iliofemoral bypass 
graft. As can be seen from Table 1, several of the 
patients studied had undergone previous vascular 
intervention. In more detail, two patients presented 
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Table 1. Details of the 10 patients treated with the crossover femoropopliteal graft 
Previous Primary 
Indication vascular  Ang iogram Inflow/ Graft patency Secondary 
Patient for bypass intervention appearances out f low material (months) intervention 
Secondary 
patency Limb 
(months) salvage Outcome 
1 Rest pain CFA endart 23 CIA, EIA, CFA, CIA/ 6mm 64 No 
and 8 yrs prev P, FA, SFA occl. AKP PTFE 
3 vessel run-off 
2 Rest pain Nil CIA, EIA, CFA, CFA / 8ram 84 No 
SFA occl. AKP PTFE 
2 vessel run-off 
3 Restpain ABF18/12prev Graftlimb, Graftlimb/ 8ram 29 No 
(rest pain) PFA, SFA occl. AKP PTFE 
Peroneal run-off 
4 Rest pain Nfl ErA, CFA, PFA, CFA/ 8mm 54 No 
SFA occl. BKP IYFFE 
2 vessel run-off 
5 Rest pain ABF 24/12 prev CFA, SFA occl. Graft limb/ 8ram 50 
(aortic 3 vessel run-off AKP PTFE 
occlusion) 
6 Gangrene CIA balloon 
angioplasty 
Yes Alive and 
well 
Graft patent 
Yes Died 
Graft patent 
Yes Alive and 
well 
Graft patent 
Yes Died (MI) 
Graft patent 
Yes 74 Yes 
Graft 
thrombectomy 
CIA, PFA, SFA CFA/ 8mm 18 Yes Nil No 
ocd. AKP PTFE Graft Failed 
Peroneal run-off thrombectomy thrombectomy 
7* Rest pain Nil CIA, bilat SFA CFA/ 8mm 49 Yes 83 No 
ocd. AKP PTFE Jump graft o Graft 
2 vessel run-off peroneal rtery occluded 
8 Infected Iliofemoral CIA, EIA, SFA CFA/ 6ram 14 No -- Yes CVA 4/12 
iliofemoral bypass 2/12 occl. AKP PTFE postop. 
bypass prey 2 vessel run-off Graft patent 
9 Rest pain Lumbar phenol CIA, EIA, CFA, CFA/ 8mm 51 No -- No Alive and 
sympathectomy PFA, SFA occl. AKP PTFE well 
2 vessel run-off 
10 Ulceration Preop stenting CIA, EIA, CFA, CFA/ 8mm 20 No -- Yes Alive and 
and rest Donor CIA PFA, SFA ocd. AKP PTFE well 
pain PT run-off Graft patent 
Alive and 
well 
Graft patent 
Survived to 
discharge 
Died (PE) 
postamp 
CIA: Common iliac artery; EIA: External f iac artery; CFA: Common femoral artery; PFA: Profunda femoris artery; SFA: Superficial femoral 
artery; AKP: Above-knee popliteal artery; BKP: Below-knee popliteal artery; PT: Posterior tibial artery; ABF: Aortobifemoral bypass; 
PTFE: Polytetrafluoroethylene; Mh Myocardial infarction; CVA: Cerebrovascular accident; PE: Pulmonary embolism; *: See Figure 1. 
with occlusion of one limb of an aortobifemoral graft, 
one had undergone common femoral endarterectomy 
and vein patch on two occasions, one had been treated 
with common iliac artery percutaneous balloon angio- 
plasty and in one case, a lumbar phenol sym- 
pathectomy had been performed prior to surgical 
intervention. In only one patient (Patient Number 10) 
was the "donor" artery treated (with balloon angio- 
plasty and stenting) prior to bypass placement. Preop- 
erative angiography demonstrated xtensive occlusive 
disease affecting the iliac and femoral arteries in all 
cases. 
Surgical exposure of the donor vessel (or graft limb) 
was via a standard groin incision in nine cases and in 
one patient, the common iliac artery was exposed 
retroperitoneally through an iliac fossa incision. The 
popliteal artery was exposed above or below the knee 
joint via a standard medial approach. In all cases, a 
small relieving incision was necessary in the groin on 
the recipient side, to allow for tunnelling of the graft. 
Grafts were placed in a subcutaneous supra-pubic 
tunnel and were then led subsartorially to the popli- 
teal artery. Details of the inflow and outflow vessels 
are shown in Table 1. The profunda femoris artery was 
not revascularised directly because it was either seen 
to be severely diseased on preoperative angiograms, 
or the extent of profunda disease was thought o be 
responsible for the failure of the two aortobifemoral 
graft limbs, or there was an infected iliofemoral graft 
present. 
Externally-reinforced polytetrafluoroethylene was 
the conduit utilised in this series, the graft diameter 
being 8mm in eight patients and 6mm in two. Details 
of postoperative morbidity and duration of hospital 
stay were noted. 
After discharge, all patients were monitored at 
regular vascular out-patient clinic visits using a 
combination of clinical assessment, ankle-brachial 
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index measurement and more recently, annual Duplex 
ultrasound scans of the grafts. Thus graft patency, 
limb salvage and patient survival were recorded. 
Results 
There was no perioperative or postoperative (30 day) 
mortality. Three patients developed a minor, short- 
lived wound complication (two lymph leaks and one 
minor infection) and two suffered chest infections that 
required treatment with antibiotics. One patient 
(patient number 8) suffered a postoperative cer- 
ebrovascular accident from which he made a good 
recovery. The median postoperative hospital stay was 
16 days (range 5-47 days) and in all but one case 
(patient number 8), patients were discharged irectly 
home. 
The median duration of primary graft patency was 
49.5 months (range 14-84). During the follow-up 
period (median 52 months, range 14-84), one patient 
(number 7) complained of recurrent rest pain. Duplex 
scanning showed the crossover femoropopliteal graft 
to be patent and subsequent angiography (Fig. 1) 
demonstrated progression of occlusive disease in the 
popliteal artery to be the cause of the recurrence of 
symptoms. A jump graft was performed to the 
peroneal artery and the patient remained asympto- 
matic for a further 34 months, at which time the graft 
thrombosed and ultimately an above-knee amputation 
was necessary. There were three other occlusive vents 
during follow-up. One graft was treated successfully 
by a balloon catheter thrombectomy and this conduit 
is still patent 74 months after the initial bypass 
procedure. In the other two cases of graft occlusion, 
patency could not be restored and major limb amputa- 
tion was required. Thus the median duration of 
secondary patency was 52.5 months (range 14-84). As 
can be seen from Table 1, long-term graft patency did 
not appear to be related to the number of calf run-off 
vessels that were patent at the time of the original 
bypass procedure. Long-term limb salvage was 
achieved in seven of the 10 patients in this series. 
During the follow-up period, three patients died, 
two from myocardial disease and one from a pulmo- 
nary embolism sustained whilst recovering from a 
limb amputation. 
Discussion 
The use of extra-anatomic bypass grafting for limb 
salvage in patients not fit for major arterial reconstruc- 
tion is not a new concept. The femorofemoral crosso- 
ver graft was first described in the 1950s by Freeman 
and Leeds 9 and its popularity was increased after the 
reports of such authors as Vetto in the early 1960s. 1° 
There is now extensive literature on the use of 
femorofemoral grafting to treat unilateral iliac artery 
Fig. 1. Angiogram taken after crossover femoropopliteal graft had 
been in place for 49 months. The patient complained ofrecurrent 
rest pain the left foot and angiography showed a patent graft in 
spite of disease progression with occlusion of the popliteal rtery 
(arrow). A jump graft was performed tothe peroneal rtery, which 
alleviated symptom s and maintained graft pateney for a further 34 
months. 
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occlusive disease and the patency rates reported by 
several authors show this to be a very durable 
procedure, with 5 year patency rates of 70% or greater 
being quoted. 6'7'11-14 The advent of catheter-guided 
endovascular therapy has meant that in many cases, 
operative intervention is no longer the primary treat- 
ment advocated by many for iliac occlusive disease, 
although the long-term patency rates of iliac artery 
balloon angioplasty and stenting have yet to be 
evaluated and so formal comparisons to extra-ana- 
tomic grafting cannot be made at this stage. There is a 
sub-group of patients that present with critical limb 
ischaemia and are found to have unilateral ather- 
omatous occlusive disease affecting both the iliac and 
the femoral arteries. In such patients, if the profunda 
femoris artery is also involved, there is no guarantee 
that revascularisation f the femoral segment will be 
adequate to alleviate symptoms. It was when faced 
with such a problem in the late 1950s, that McCaughan 
and Kahn suggested taking a graft from the asympto- 
matic side's external iliac artery to the above-knee 
popliteal artery on the contralateral, symptomatic 
side. ~5 This graft was tunnelled extraperitoneally 
above the bladder and was also anastomosed side-to- 
side to the profunda femoris artery. These authors 
achieved limb salvage in both of the patients they 
reported in which this operative approach was used. 
Since then, this configuration of extra-anatomic 
bypass has been described in the vascular surgical 
textbooks. 19 However, the only other significant 
reports in the vascular surgical literature of the 
crossover femoropopliteal bypass have come from 
Schuler et al. In 1984, they reported a series of 13 such 
grafts, 10 of which consisted of a single length of 
prosthetic graft taken from the donor side common 
femoral artery to the contralateral popliteal arter}5 
with a side-to-side anastomosis to the profunda 
femoris, and three grafts in which a prosthetic 
femorofemoral bypass was augmented by an auto- 
genous vein femoropopliteal graft, taken from the 
hood of the crossover graft's distal anastomosis to the 
popliteal artery of the affected limb. 16 They quoted a 
42 month patency rate of 91% for the femorofemoral 
portion of such grafts and 63% for the distal segment. 
The limb salvage rate was 88%. In a subsequent 
publication from the same group, 17 in which their 
experience over 9 years utilising this technique in 21 
patients was reviewed, they reported a 5 year primary 
patency rate of 57% for the femorofemoral segment 
and a 40% for the femoropopliteal segment, in 
association with a limb salvage rate of 77%. The 
interesting differences between the present series and 
these two reports are two-fold. First, it has not been 
our practice to revascularise directly the profunda 
femoris artery on the symptomatic side. In all of the 
patients reported here, this vessel was either seen to be 
severely diseased angiographically, or had been asso- 
ciated with the failure of an aortobifemoral graft limb 
or was involved in an infected field and it was felt that 
the thigh would be perfused satisfactorily through 
collaterals via retrograde flow from the distal anasto- 
mosis. Second, all of our patients required bypass for 
limb salvage whereas, Schuler's group placed a 
number of these grafts to treat patients with inter- 
mittent claudication. 
In 1978, Veith et ~l. described a variety of interesting 
extra-anatomic grafts placed for limb salvage. 18 
Included in their series were five grafts taken from one 
femoral artery to the opposite popliteal or even to the 
tibial vessels. The mean patency of this sub-group of 
grafts was 12 moa~,ths, with the longest duration of 
patency being 17 months. Limb salvage was achieved 
in four of these patients. 
We believe that for this sub-group of patients with 
multi-leveL unilateral atheromatous occlusive dis- 
ease, the crossover femoropopliteal graft is a useful 
therapeutic option. In our experience, this technique 
was associated with minimal intra- and postoperative 
morbidity and all but one of the patients tudied were 
discharged directly home. Long-term graft patency 
was satisfactory and correlated with limb salvage. 
Follow-up surveillance identified one threatened graft 
which was revised successfully by means of a distal 
jump graft thereby extending patency (and limb 
salvage) by a furtLher 34 months. Graft occlusion 
occurred in a total of four bypasses, only one of which 
was reopened successfully. The fact that the other 
three occlusive vents were associated ultimately with 
limb amputation confirmed the degree of limb threat 
that existed in these patients and suggested that 
progression of occlusive disease may have been a 
significant factor in late graft failure. However, there 
did not seem to be a correlation between the number 
of patent infrapopliteal vessels seen on preoperative 
angiography and the long-term patency of the graft. 
In conclusion, the femoropopliteal crossover graft 
offers a practicable solution to the problem of limb 
salvage in the small sub-group of patients who have 
concomitant, unilateral iliac and femoral occlusive 
disease in whom major aortic surgery is not possible 
due to intercurrent cardiorespiratory disease and in 
whom the extent of disease precludes conventional 
operative or endovascular intervention. 
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